Fundraising Fox
Absco Therapeutics
Allston, US · Founded 2024 · Delaware corporation
Find your way into Absco Therapeutics
Sign up to see every warm intro you have to Absco Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Absco Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Absco Therapeutics develops a drug delivery platform based on thermogelling polymers that shift from liquid to solid at body temperature to form controlled-release depots for sustained, on-target therapy. Its lead candidate ABS005 is a non-surgical intralesional treatment for high-grade cervical intraepithelial neoplasia (CIN2/3), with the platform targeting cancers and precancers.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$7M disclosed across 2 rounds · 2024–2025
▶$5MraisedAug 2025 · 1 investors · BiotechnologyRule 506(b)
- Stephen LindermanExecutive Officer, Director
- Carlo Giovanni TraversoDirector
- Avik SomDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$2MraisedMay 2024 · 1 investors · BiotechnologyRule 506(b)
- Avik SomDirector
- Carlo Giovanni TraversoDirector
- Stephen LindermanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Absco Therapeutics went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Absco Therapeutics.
Frequently asked questions
- What does Absco Therapeutics do?
- Absco Therapeutics develops a drug delivery platform based on thermogelling polymers that shift from liquid to solid at body temperature to form controlled-release depots for sustained, on-target therapy. Its lead candidate ABS005 is a non-surgical intralesional treatment for high-grade cervical intraepithelial neoplasia (CIN2/3), with the platform targeting cancers and precancers.
- How much funding has Absco Therapeutics raised?
- Absco Therapeutics has disclosed $7M raised across 2 rounds.
- Where is Absco Therapeutics headquartered?
- Absco Therapeutics is headquartered in Allston, US.